GVK BIO: Goldman Sachs PE emerges frontrunner to acquire ChrysCap stake in GVK Biosciences

The private equity arm of Wall Street powerhouse Goldman Sachs has entered the final stage of negotiations to buy out the minority stake held by ChrysCapital in top contract research player GVK Biosciences, people with knowledge of the matter told Moneycontrol. If talks fructify, this would be the second domestic pure play pharma investment by [...] The post Goldman Sachs PE emerges frontrunner to acquire ChrysCap stake in GVK Biosciences appeared first on Medical Buyer.